BBLG FY 2017 Earnings — Bone Biologics Corporation Revenue & Financial Results | Market Cap Arena

BBLGBone Biologics Corporation

$2M

FY 2017 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$0

Gross Profit

-$96

Operating Income

-$3M

Net Income

-$7M

EPS (Diluted)

$-6480.00

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$3M

Stock-Based Comp.

-$584,027

Balance Sheet

Total Assets

$795,659

Total Liabilities

$9M

Stockholders' Equity

-$8M

Cash & Equivalents

$690,279

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$96	-$700	+86.3%
Operating Income	-$3M	-$20M	+87.1%
Net Income	-$7M	-$26M	+72.8%